San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

There at the Start(up)

BIOTECH: Hybritech’s Story Is First Chapter of S.D.’s Biotech Biography

The name Hybritech is pinned to local resumes like a badge of honor, as if to say, “I was here in the beginning.”

Richard Slansky Appointed CFO at OncoSec Medical Inc.

OncoSec Medical Inc., a company developing cancer immunotherapies, announced Thursday the appointment of Richard B. Slansky as chief financial officer effective July 6.

Palomar Health to Close Downtown Escondido Hospital

Palomar Health's Board of Directors voted Wednesday night to close Palomar Health Downtown Hospital in Escondido.

Aethlon Medical Enters $6 Million Stock Purchase Agreement

San Diego-based Aethlon Medical Inc., a medical device company developing therapies for infectious diseases and cancer, announced Wednesday that it entered into a definitive $6 million stock purchase agreement.

FDA Grants ARK Animal Health MUMS Drug Designation

ARK Animal Health Inc., a wholly-owned subsidiary of San Diego-based Sorrento Therapeutics Inc., was granted a Minor Use/Minor Species (MUMS) Drug Designation for its pain drug, ARK-001, for dogs with bone cancer.

Conrad Prebys Donates $100 Million to Sanford-Burnham Institute

The Sanford-Burnham Medical Research Institute announced Wednesday that it has received a gift of $100 million from prominent San Diego developer and philanthropist Conrad Prebys.

Imprimis Acquires Rights to Sedation Formulations

Imprimis Pharmaceuticals Inc. has acquired the rights to novel sedation and analgesia/anesthesia formulations that can block pain and sedate patients undergoing ocular and other surgical procedures.

Premier Inc. Awards AMN Healthcare Sole Source Contract

San Diego’s AMN Healthcare Services, the country’s largest provider of health care staffing services, has won a sole source contract with Premier Inc. to offer staffing services and workforce solutions to its alliance of about 3,400 hospitals and 110,000 other health care facilities.

Ambrx Inc. Appoints CEO, Chief Science Officer

Ambrx Inc., a San-Diego based biotechnology company, has named Tiecheng (Alex) Qiao its CEO effective immediately.

Wearables Are a Fit With S.D.’s Health Care and Tech Clusters

HEALTH: Devices Could Be Game Changer for Health Care, Expert Says

Apple’s latest gadget ― the iWatch ― has spurred a massive influx of digital health companies to enter the already popular wearables market, industry analysts said.

Tease photo

ATyr Pharma Reports Q1 Results

San Diego-based aTyr Pharma Inc. reported a net loss of $9.1 million for the first quarter of 2015, up from a net loss of $6.2 million in the same period last year.

Salk Institute Scientist Named Pew Scholar

The Pew Charitable Trusts announced recently that Salk Institute for Biological Studies scientist Nicola Allen, an assistant professor in the Molecular Neurobiology Laboratory, is one of 22 researchers to be named a Pew Scholar in the biomedical sciences.

Organovo Announces $40M Underwritten Public Offering

San Diego 3-D bioprinting company Organovo Holdings Inc. announced Thursday a $40 million underwritten public offering of its common stock.

SDSU, USD Partner on Program Focused on Life Sciences Industry

San Diego State University College of Sciences and the University of San Diego School of Law are partnering on a new program that prepares students for upward career mobility in the growing life sciences industry.

Batu Biologics Completes $1 Million Seed Round of Funding

Batu Biologics, an immuno-oncology company, announced Wednesday that it has successfully completed a $1 million seed round of funding.